Ferring USA in Parsippany employs more than 900 individuals. Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany June 17, 2025.

The ADAPT-1 trial was a multicentre, randomised, assessor-blind study involving 300 women aged 18-40 years undergoing IVF or ICSI. 3 The trial compared the efficacy and safety of follitropin delta ...

Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which ...

PARIS, July 02, 2025--Follitropin delta starting dose of 15 micrograms (µg)/day has comparable efficacy and safety as a starting dose of 225 International Units (IU)/day of follitropin alfa for ...

Ferring and Rebiotix claim a first in microbiome therapy, as RBX2660 hits the market in a phase 3 C. diff trial, setting up filing talks with the FDA ...

Information on UI treatment was obtained from the Danish National Prescription Registry, and other national registries provided data to identify children treated as inpatients or outpatients for ...

The financing was co-led by Ferring Ventures S.A. and Apeiron Investment Group, the family office of atai Founder and Chairman Christian Angermayer, with participation from new and existing ...

Safdar reported relationships with Ferring and Nestle. Co-authors reported support from AstraZeneca, Ferring, Moderna, Pfizer, ProbioTech, Rise, Takeda, and Vedanta.

These days, it seems no operatic mountain is too high for Haymarket Opera. The company’s latest enterprise, Leonardo Vinci’s “Artaserse,” is one such intimidating peak. The rarely staged ...

Merck Manuals launches AI-powered search, offering patients fast, trusted answers from its widely used medical manuals and resources.

The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firedenovec-vncg) for the treatment of adult patients with high-risk ...

Aatish Pattani joined Ferring Pharmaceuticals in September 2024. He has previously held positions including head of compensation and reward, and HR operations. During his career, he has spearheaded ...